EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The use of biologic disease-modifying antirheumatic drugs does not increase surgical site infection or delayed wound healing after orthopaedic surgeries for rheumatoid arthritis

Yohei Kiso iD, Keiichiro Nishida iD, Ryozo Harada, Yoshihisa Nasu, Ryuichi Nakahara, Yoshifumi Hotta, Shuichi Naniwa, Toshifumi Ozaki

Modern Rheumatology · 2025

DOI: 10.1093/mr/roae089 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2025. Verfasst von Yohei Kiso und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Surgical Wound Infection, Antirheumatic Agents, Wound Healing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the effect of the use of biologic disease-modifying antirheumatic drugs (bDMARDs) on surgical site infection (SSI) and delayed wound healing (DWH) in rheumatoid arthritis (RA) patients undergoing orthopaedic surgery.

Methods

We retrospectively reviewed the records of 965 elective orthopaedic procedures undertaken in RA patients. The incidences of SSI and DWH were compared between the bDMARDs user and nonuser groups. Subsequently, univariate and multivariate logistic regression analyses were performed to evaluate risk factors for SSI and DWH after propensity score matching. The incidence of postoperative flare-up was also examined.

Results

In 965 procedures, SSI and DWH were identified in 12 and 28 cases, respectively. SSI and DWH were identified in 3 and 17 of 414 procedures treated with bDMARDs, respectively. Flare-up occurred in 21 cases. Propensity score matching identified 315 cases in both groups, with no significant difference in incidence between the two groups. No risk factors for SSI were identified, whereas age, diabetes mellitus, foot and ankle surgery, and a history of musculoskeletal-related infection were identified as risk factors for DWH.

Conclusion

The use of bDMARDs was not associated with an increased incidence of SSI or DWH, with the incidence of flare-up being relatively low.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSurgical Wound InfectionAntirheumatic AgentsWound HealingOrthopedic ProceduresBiological ProductsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedRisk FactorsAdultIncidence

Stichwörter der Autor:innen

Biologic DMARDsdelayed wound healingorthopaedic surgeryrheumatoid arthritissurgical site infection

Substanzen

Antirheumatic AgentsBiological Products

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Locomotive Pain Center, Okayama University Hospital, Okayama, Japan.
  • Department of Orthopaedic Surgery, Kurashiki Sweet Hospital, Okayama, Japan.
  • Department of Orthopaedic Surgery, Okayama University Hospital, Okayama, Japan.

ORCID-Profile: Yohei Kiso, Keiichiro Nishida

Zitieren

APA

Kiso, Y., Nishida, K., Harada, R., Nasu, Y., Nakahara, R., Hotta, Y., Naniwa, S., & Ozaki, T. (2025). The use of biologic disease-modifying antirheumatic drugs does not increase surgical site infection or delayed wound healing after orthopaedic surgeries for rheumatoid arthritis. Modern Rheumatology. https://doi.org/10.1093/mr/roae089

Vancouver

Kiso Y, Nishida K, Harada R, Nasu Y, Nakahara R, Hotta Y, et al. The use of biologic disease-modifying antirheumatic drugs does not increase surgical site infection or delayed wound healing after orthopaedic surgeries for rheumatoid arthritis. Modern Rheumatology. 2025. doi:10.1093/mr/roae089

BibTeX
@article{Kiso2025,
  author = {Kiso, Yohei and Nishida, Keiichiro and Harada, Ryozo and Nasu, Yoshihisa and Nakahara, Ryuichi and Hotta, Yoshifumi and Naniwa, Shuichi and Ozaki, Toshifumi},
  title = {The use of biologic disease-modifying antirheumatic drugs does not increase surgical site infection or delayed wound healing after orthopaedic surgeries for rheumatoid arthritis},
  journal = {Modern Rheumatology},
  year = {2025},
  doi = {10.1093/mr/roae089}
}
Kostenlos starten →